Vanda Pharmaceuticals Announces Completion of Transfer of FDA Marketing Authorization for PONVORY® marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
WASHINGTON, April 22, 2024 /PRNewswire/ Vanda Pharmaceuticals Inc. today announced that the Supreme Court denied Vanda s petition for a writ of certiorari in its HETLIOZ® Abbreviated New Drug.
Vanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial of its Petition in HETLIOZ® ANDA Litigation streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Vanda Pharmaceuticals (VNDA) Reacts to U.S. Supreme Court's Denial of its Petition in HETLIOZ streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
The FDA has expanded the approval of Fanapt® (iloperidone) to include the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults.